Oxford Textbook of Clinical Nephrology

Neil Turner has been Professor of Nephrology at the University of Edinburgh since 1998. After broad experience of general medicine he worked in renal units in Oxford, Hammersmith, and Aberdeen before moving to Edinburgh. His major research and clinical interests are currently in genetic diseases of the glomerular basement membrane, and in paediatric-adult transition. Professor Turner is involved in international educational activities through both EdinburghUniversity and the International Society of Nephrology.Professor Goldsmith is a Consultant Nephrologist at Guys and St Thomas' Hospitals; Professor, Cardiovascular and Cell Sciences Institute, St Georges University of London; and Professor of Nephrology in Gr. T. Popa University of Medicine and Pharmacy, Romania. He is also Clinical Director of the NIHR South London Clinical Research Network. He is a Fellow of both the American Society of Nephrology and also the European Renal Association-EDTA. He was Co-Editor of the Journal of Nephrology(2006-2009), and was Associate Editor of CJASN (2010-2014). He is the Associate Editor of International Journal of Clinical Practice (2014 -), and on the Editorial Boards of Nephrology, Dialysis and Transplantation, CJASN, CardioRenal Medicine, and International Urology and Nephrology.Dr. Jonathan Himmelfarb is Director of the Kidney Research Institute, Professor of Medicine, and holds the Joseph W. Eschbach M.D. Endowed Chair in Kidney Research at the University of Washington. He is also President-elect of the American Society of Nephrology (ASN) in 2014-2015. He has served on numerous editorial boards, including the Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, Kidney International, Faculty of 1000 in Medicine, andthe Faculty of 1000 in Research. Current research interests include studies on a wearable artificial kidney; development of a human 'kidney-on-a-chip', and development and evaluation of risk biomarkers in acute and chronic kidney disease.Dr Chris Winearls graduated from the University of Cape Town in 1973. He completed a PhD in transplant immunology at Oxford University before training in nephrology at the Royal Postgraduate Medical School and the Hammersmith Hospital, London, where he was part of the team that investigated the first clinical use of recombinant human erythropoietin. He was appointed consultant nephrologist in Oxford in 1988 and was Clinical Director 1995 to 2009. Dr Winearls is currently a Fellow of JesusCollege Oxford and an Hon Senior Lecturer in Medicine at the University of Oxford. His research interests include paraprotein disorders affecting the kidney, ADPKD, The CKD construct and renal anaemia.With expert input from section editors William G. Bennett, Marc E. De Broe, Jeremy R. Chapman, Adrian Covic, Vivekanand Jha, Neil Sheerin, Robert Unwin and Adrian Woolf